Last update:

Weight management news

Distinct brain circuits explain contradictory behaviors of new weight-loss drugs

Cambridge scientists have solved the mystery of why both stimulating and blocking a particular "switch" in the brain can help people lose weight—findings that could help boost the effectiveness of obesity drugs.

Biomarker discovery could advance treatments for obesity-related health risks

Researchers have identified a biological marker that rises and falls as body fat changes, offering new insight into how weight gain and weight loss may influence metabolic health.

It's not just fat: Yo-yo dieting might mean losing muscle, too

Repeatedly losing and gaining weight may do more than frustrate dieters—it also accelerates muscle loss in middle-aged people, according to new UC San Francisco research that comes as weight-loss medications transform obesity ...

Women with PMOS at four-fold higher risk of heart disease

Women with polyendocrine metabolic ovarian syndrome (PMOS; also known as polycystic ovary syndrome or PCOS) face a fourfold higher risk of heart disease than women without PMOS, according to a new nationwide U.S. study published ...

Q&A: Psychedelics, cannabis, GLP-1s and drug policy changes

From headlines and social media, psychedelic therapies, cannabis use and GLP-1 medications have seemingly become commonplace overnight, but the science underlying these treatments and the pathway to drug approval are often ...

Researchers study barriers to GLP-1 insurance coverage

Despite growing evidence that GLP-1 medications improve health and are worth their cost, many insurance plans still limit coverage. University of Mississippi researchers are examining why and where that leaves patients.

Aussie supermarkets failing to help us eat a healthier diet

New research presented at this year's International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (July 15–17), reveals that few of the world's 21 largest food retailers ...

Rise of GLP-1s raises long-term affordability questions

As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022. ...

What's driving the obesity pandemic?

New research presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, (15–17 July) asks what is driving the obesity pandemic.